Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017, Article ID 6915912, 14 pages
https://doi.org/10.1155/2017/6915912
Research Article

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma

1Cancer Institute, Xuzhou Medical University, Xuzhou, Jiangsu 221002, China
2Department of Immunology, Binzhou Medical University, Yantai, Shandong 264003, China
3Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical College, Xuzhou, Jiangsu 221002, China

Correspondence should be addressed to Huizhong Li; nc.ude.umhzx@zhl and Junnian Zheng; nc.ude.umhzx@gnehznj

Received 7 August 2017; Revised 17 September 2017; Accepted 8 October 2017; Published 20 December 2017

Academic Editor: Rosa Molfetta

Copyright © 2017 Qing Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Qing Zhang, Kang Tian, Jinjing Xu, et al., “Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma,” Journal of Immunology Research, vol. 2017, Article ID 6915912, 14 pages, 2017. https://doi.org/10.1155/2017/6915912.